Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021

 We write to inform you that the Board of Directors of the Company at its meeting held on November 12, 2021, has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2021 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Reports dated November 12, 2021 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 3.00 p.m. and concluded at 3.55 p.m.
12-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On November 12, 2021

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 2, 2021 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on November 12, 2021, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) and Sakal, Mumbai (Marathi version) on page no. 9 dated November 3, 2021 for your reference and record.
03-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 We hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 12, 2021, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2021. The 'Trading Window" (period for trading in Company's securities) has been closed with effect from October 1, 2021 and shall continue to remain closed till 48 hours after declaration of unaudited financial results for the quarter and half year ended September 30, 2021. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their immediate relatives.
02-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday, November 12, 2021

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 12, 2021, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2021.
02-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Shareholding for the Period Ended September 30, 2021

 Fermenta Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
20-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Wednesday, October 20, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
19-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Monday, October 18, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
18-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Srikant N SharmaDesignation :- Company Secretary and Compliance Officer
13-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended September 30, 2021, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Transfer Agent - Link Intime India Private Limited, which is enclosed herewith.
13-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analyst / Institutional Investor over conference call on Wednesday, October 13, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
12-10-2021
Next Page
Close

Let's Open Free Demat Account